ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

 

Brief Oral Communications (Clinical)
08:29

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

The Technical Decline in the Rate of CML Treatment-free Remission in Aging Countries: the French Experience

FEATURING Marc Delord
  • 6 views
  • December 13, 2018
06:58

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Patients’ Perspectives on the Definition of Cure in Chronic Myeloid Leukemia: a US Based Survey

FEATURING Gemlyn George
  • 9 views
  • January 2, 2019
08:10

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Long-term Outcomes of Early CP CML Patients who Have Achieved CCyR but not MMR After 24 Months on Frontline Imatinib Therapy

FEATURING Sung-Huyn Kim
  • 11 views
  • January 2, 2019
06:31

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Prevalence and Outcomes of Uncommon BCR-ABL Fusion Transcripts in Patients with CML: Data from a Single Center

FEATURING Qian Jiang
  • 10 views
  • January 2, 2019
05:34

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Cumulative Incidence of Treatment-free Remission (TFR) for Patients with Chronic Myeloid Leukemia (CML): The Adelaide Experience

FEATURING Naranie Shanmuganathan
  • 10 views
  • January 2, 2019